Clinical Trial Update: A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee [Phase 1]

View source ↗

Summary

A Phase 1 safety and tolerability study of PF-05089771 in healthy subjects and in individuals with osteoarthritis of the knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• PF-05089771 (PF-05089771)

Snippet

Sponsor: Pfizer | Conditions: Pain | Phase 1 | Status: COMPLETED